Date of Award


Document Type


Degree Name

Doctor of Philosophy (PhD)


Biomedical Sciences


Microbiology, Immunology, and Biochemistry

Research Advisor

Stephania A. Cormier, Ph.D.


John P. DeVincenzo, M.D. Elizabeth A. Fitzpatrick, Ph.D. Kui Li, Ph.D. Christopher M. Waters, Ph.D.


Dendritic cells, Neonates, RSV, Th2


Respiratory syncytial virus (RSV) is one of the leading causes of bronchiolitis in children. We have shown that neonatal mice respond to primary RSV infection with T helper type 2 (Th2) biased immune responses, which are enhanced following reinfection. Dendritic cells (DCs) including myeloid DCs (mDCs) and plasmacytoid DCs (pDCs) play important roles in driving host responses to RSV infection. mDCs present antigens to help Th cells differentiate, and pDCs protect against viral infection through type I interferons (IFNs). Despite data demonstrating importance of mDCs and pDCs in protection against RSV, it has not been studied in an age appropriate model. Using a neonatal mouse model, we have shown that downregulation of IL-4 receptor alpha (IL-4Rα) on pulmonary myeloid dendritic cells (mDCs) via antisense oligonucleotides protected against RSV induced Th2 immunopathology. Thus, we examined the role of IL-4Rα on mDCs in RSV infection. Here, we discovered that IL-4Rα is developmentally regulated such that neonates have higher levels of IL-4Rα on mDCs. To determine if this elevated expression of IL-4Rα on mDCs was responsible for RSV pathogenesis in neonatal mice, we specifically deleted it from neonatal mDCs (or overexpressed it on adult mDCs) and studied RSV pathogenesis using our neonatal mouse model of RSV infection. Deletion of IL-4Rα from mDCs in our neonatal RSV infection model resulted in reduced disease as evidenced by reduction in Th2 biased inflammation and mucus cell hyperplasia and production. This was accompanied by improved lung function and enhanced mDC maturation status after infection. Furthermore, overexpression of IL-4Rα on adult mDCs was able to induce RSV disease similar to that observed in our neonatal model of RSV infection (i.e., Th2 biased responses including mucus hyperproduction). In vitro CD4+ T cell differentiation assays using mDCs from neonatal littermate control or IL-4Rα-/- mice were also performed to determine the specificity of the in vivo response. Low levels of type I IFNs have been reported in the nasal aspirates of RSV-infected infants. Since pDCs are responsible for a significant proportion of type I IFN production, we characterized the role of type I IFNs and pDC responses in the immunopathogenesis during RSV reinfection in our neonatal mouse model. We found that neonatal pDCs, while recruited to the airways, are recruited in low numbers in the response to neonatal RSV infection. Further, those pDCs that are recruited produce insufficient quantities of type I IFNs. Supplying IFN-α or adult pDCs locally to the neonatal mouse prior to RSV infection in neonates abrogated RSV induced immunopathophysiologies and this protection remained even after reinfection. Specifically, it reduced Th2 responses and lung inflammation and improved lung function. This improvement was due to a decrease in viral load and IL-4Rα expression on Th2 cells after IFN-α treatment. The severity of RSV pathogenesis in infants stems partly from immature immune responses. Our data demonstrate that developmentally regulated IL-4Rα expression on mDCs and inefficient type I IFN production from neonatal pDCs are critical for protection against RSV induced immunopathophysiologies. This study highlights critical differences between neonatal and adult DCs in RSV infection.